Eiger BioPharmaceuticals, Inc. Quarterly Inventory, Net in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Inventory, Net history and growth rate from Q4 2020 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Inventory, Net for the quarter ending December 31, 2023 was $1.56M, a 45.5% decline year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.56M -$1.3M -45.5% Dec 31, 2023 10-K 2024-04-08
Q3 2023 $1.11M -$1.71M -60.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.1M -$1.78M -61.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $5.34M +$3.43M +179% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.85M +$241K +9.23% Dec 31, 2022 10-K 2024-04-08
Q3 2022 $2.82M +$196K +7.48% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $2.88M +$811K +39.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $1.91M +$513K +36.7% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.61M +$2.52M +2709% Dec 31, 2021 10-K 2023-03-17
Q3 2021 $2.62M Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $2.07M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.4M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $93K Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.